Prophase Labs Inc PRPH
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 1984-01-16 |
| Shares Out. | 14,020,000 |
| Website | prophaselabs.com/ ↗ |
| Phone | 12153450919 |
| Employees | 96 |
| Revenue | $883,000 |
| Gross Profit | -$123,000 |
| Net Income | -$6.8M |
| Total Assets | $65.7M |
| Total Liabilities | $58.8M |
| Equity | $6.9M |
About Prophase Labs Inc
ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.
Prophase Labs Inc is a publicly traded company under the ticker symbol PRPH on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
7 analysts (2025-03-01)